| ML067119a |
SPRY domain containing 3 |
— |
— |
0.557 |
| ML032918a |
WBP2 N-terminal like |
— |
— |
0.555 |
| ML35608a |
cathepsin Q |
— |
— |
0.552 |
| ML070813a |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 |
— |
Chromatin |
0.551 |
| ML18592a |
RAB2B, member RAS oncogene family |
— |
— |
0.550 |
| ML073267a |
— |
— |
— |
0.549 |
| ML03006a |
junctophilin 3 |
— |
— |
0.545 |
| ML001512a |
AKT1 substrate 1 |
— |
— |
0.537 |
| ML05499a |
— |
— |
— |
0.535 |
| ML02994a |
mitogen-activated protein kinase kinase 1 |
— |
Signalling |
0.533 |
| ML086435a |
cytidine/uridine monophosphate kinase 1 |
— |
— |
0.533 |
| ML111722a |
— |
— |
RNA-binding proteins |
0.531 |
| ML161319a |
ribosome production factor 1 homolog |
— |
— |
0.530 |
| ML00533a |
— |
— |
— |
0.527 |
| ML09558a |
surfeit gene 1 |
— |
— |
0.527 |
| ML306118a |
upstream transcription factor 2 |
— |
Transcription factors |
0.523 |
| ML04304a |
— |
— |
— |
0.523 |
| ML033612a |
leucine, glutamate and lysine rich 1 |
— |
— |
0.519 |
| ML02002a |
— |
— |
— |
0.517 |
| ML049024a |
protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform |
— |
— |
0.514 |
